Michael Nelson is the CEO of Intrommune Therapeutics, while Dr. Bill Reisacher sits on its scientific advisory board.
One Business Partner Managed a Billion-Dollar Portfolio at Barclays, the Other Heads an Ivy League Medical School Department. Can They Create a Unicorn Together?
